Shionogi Updates Zatolmilast Study Protocol For Fragile X Syndrome
18 Jul 2024 //
BUSINESSWIRE
Zatolmilast Receives Rare Pediatric Disease Designation from the U.S. FDA
27 Sep 2023 //
BUSINESSWIRE
18 Jul 2024 //
BUSINESSWIRE
27 Sep 2023 //
BUSINESSWIRE